B
BioXcel Therapeutics, Inc. (BTAI)
NCM – Real Time Price. Currency in USD
1.19
-0.01 (-0.83%)
At close: May 12, 2026, 4:00 PM EDT
1.17
-0.02 (-1.63%)
After-hours: May 12, 2026, 7:50 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.19
-0.01 (-0.83%)
At close: May 12, 2026, 4:00 PM EDT
1.17
-0.02 (-1.63%)
After-hours: May 12, 2026, 7:50 PM EDT
No Data
There are no news for this stock.
Total debt $119.4M significantly exceeds cash reserves ($28.8M), raising financial stability concerns
Total current liabilities $53.9M surpass Total current assets $44.7M, signaling liquidity issues
Debt-to-equity ratio (-1.3) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-2.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$14.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.83 | 2.52 | 5.0 | |
| Quick ratio | 0.82 | 1.78 | 5.0 | |
| Debt to Equity | N/A | -0.80 | 1.0 | |
| Debt to Assets | 2.51 | 0.73 | 1.0 | |
| Interest coverage | -2.31 | -13.90 | 1.0 | |
| Weighted average score | 2.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 375K | 1M | 2M | 642K | 642K |
| Gross Profit | 28K | -198K | -186K | 178K | 178K |
| Operating Income | -158M | -166M | -63M | -50M | -50M |
| Net Income | -166M | -179M | -60M | -70M | -70M |
| EBITDA | -158M | -166M | -63M | -49M | -49M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 130.6 | 64.5 | 10 |
| Next quarter | 245.33 | 81.33 | 10 |
| Current year | 156.25 | 68.5 | 10 |
| Next year | 1050.9 | 8.59 | 8.0 |
| Weighted average score | 9.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 161.22 | 59.42 | 73.39 | 24.36 | 10 |
| Y/Y | -30.04 | -15.52 | 83.75 | 4.04 | 4.0 |
| 3y average | 86.85 | 13.81 | 49.29 | 19.71 | 9.3 |
| 5y average | 451.71 | -8.73 | 18.97 | -5.74 | 5.3 |
| Weighted average score | 7.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |